scholarly journals CD171 Multi-epitope peptide design based on immuno-informatics approach as a cancer vaccine candidate for glioblastoma

2022 ◽  
pp. 1-13
Author(s):  
Seyed Amir Hossein Mohammadzadeh Hosseini Moghri ◽  
Ghanbar Mahmoodi Chalbatani ◽  
Mojtaba Ranjbar ◽  
Catarina Raposo ◽  
Arefeh Abbasian
Keyword(s):  
Cancer Vaccine ◽  
Vaccine Candidate ◽  
Peptide Design ◽  
Epitope Peptide

scholarly journals Immunoinformatics Study on Early 4 Protein of Human Papillomavirus Type 16 for Cervical Cancer Vaccine Peptide Candidate

2019 ◽  
Vol 4 (2) ◽  
pp. 252-262
Author(s):  
Yani Suryani ◽  
Opik Taupiqurrohman ◽  
Muhammad Yusuf ◽  
Toto Subroto ◽  
Sukma Nuswantara
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Amino Acid ◽  
Cancer Vaccine ◽  
Vaccine Candidate ◽  
Peptide Vaccine ◽  
Human Papillomavirus Type 16 ◽  
Cervical Cancer Vaccine ◽  
Peptide Candidate

 The aims of this study were to carry out testing of the early 4 protein of type 16 HPV through immunoinformatics meth-ods in an effort to get the peptide vaccine candidate for cervical cancer. The software used are IEDB-AR, CABSdock and Accelrys Discovery Study 4.5. Based on the analysis that sequence of ami-no acid lysine, leucine, leucine, glycine, serine, threonine, tryp-tophan, proline and threonine (KLLGSTWPT) and the sequence of amino acid tyrosine, tyrosine, valine, leucine, histidine, leucine, cysteine, leucine, alanine, alanine, threonine, lysine, tyrosine, pro-line and leucine (YYVLHLCLAATKYPL) are peptide vaccine can-didate for cervical cancer from the early 4 protein of HPV type 16 

Functionality of insect-cell-derived colorectal cancer vaccine candidate protein EpCAM-Fc in human dendritic cells

2015 ◽  
Vol 45 (3) ◽  
pp. 162-166 ◽  
Author(s):  
Yo Seph Park ◽  
Jeong-Hwan Lee ◽  
Jin-Yeon Park ◽  
Han Sung Hwang ◽  
Martin Zenke ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Dendritic Cells ◽  
Cancer Vaccine ◽  
Insect Cell ◽  
Vaccine Candidate ◽  
Candidate Protein ◽  
Human Dendritic Cells

A randomized placebo-controlled phase II study with the cancer vaccine candidate IGN101 in patients with epithelial cancers

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 2555-2555 ◽  
Author(s):  
G. Himmler ◽  
A. Settaf ◽  
F. Groiss ◽  
N. Eller ◽  
M. Salzberg ◽  
...  
Keyword(s):  
Phase Ii ◽  
Cancer Vaccine ◽  
Vaccine Candidate ◽  
Phase Ii Study ◽  
Epithelial Cancers

β-Glucan as an immune activator and a carrier in the construction of a synthetic MUC1 vaccine

2019 ◽  
Vol 55 (2) ◽  
pp. 253-256 ◽  
Author(s):  
Hanxuan Wang ◽  
Bing Yang ◽  
Yinglu Wang ◽  
Fen Liu ◽  
Alberto Fernández-Tejada ◽  
...  
Keyword(s):  
Cancer Vaccine ◽  
Vaccine Candidate ◽  
Peptide Antigen

We describe the preparation of a cancer vaccine candidate by conjugating a MUC1 peptide antigen to the β-glucan polysaccharide, which serves both as a carrier and an immune activator.

Sign in / Sign up

Export Citation Format

Share Document